Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q1 FY2013 Earnings Presentation
21 slides from Apollo Hospitals Enterprise's earnings presentation, August 2012
Slide 1: Q1 FY 2013 Earnings Update
Q4 FY 2012 Earnings Update Q1 FY 2013 Earnings Update 1
Slide 2: Safe Harbour
Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 3: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Highlights – (1/2) Financial Performance
Highlights – (1/2) Q1FY13 Consolidated Revenues of Rs Rs. 8 8,813 813 mio (up 21.8% 21 8% yoy) Financial Performance Q1FY13 Consolidated EBITDA of Rs. 1,480 mio (up 24.0% yoy) Q1FY13 Consolidated EBITDA margin at 16.8% as compared to 16.5% in Q1FY12 C Consolidated lid t d PAT off Rs. R 787 m
Slide 5: Highlights – (2/2) Capacity
Highlights – (2/2) 49 hospitals with total bed capacity of 7,946 beds as on June 30, 2012 C Capacity it 36 owned hospitals including JVs/ Subsidiaries and associates with 5,908 beds and 13 Managed hospitals with 2,038 beds. Of the 5,908 owned beds, 5,218 beds were operational and had an occupa
Slide 6: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance
Consolidated Financial Performance ` Mio Q1 FY 12 Q1 FY 13 yoy (%) Income from Operations 6,787 8,256 21.6% Add: Share of JVs 447 557 24 5% 24.5% Total Revenues 7,234 8,813 21.8% EBITDA 1,194 1,480 24.0% margin (%) 16.5% 16.8% 29 bps Profit After Tax 545 787 44.2% Total Debt 7,979 Cash & Cash equiva
Slide 8: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance – (1/2)
Standalone Financial Performance – (1/2) ` Mio Q1 FY 12 Q1 FY 13 yoy (%) Key Highlights Revenue 6,410 7,774 21.3% Revenues of Rs. 7,774 mio, 21.3% yoy growth. Operative Expenses 3,381 3 381 3,997 3 997 18.2% 18 2% Employee Expenses 962 1,257 30.7% Administrative & Other Expenses 1,008 1,215 20.6%
Slide 10: Standalone Segment-wise Performance – (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio Q1 FY 12 Q1 FY 13 yoy (%) Key Highlights Revenues from each segment Heathcare Services * 4,514 5,299 17.4% Healthcare services Revenues at Rs. 5,299 mio, 17.4% yoy Stand-alone Pharmacy 1,898 2,477 30.5% growth. Other Income 47 41 Total 6,458 7,816
Slide 11: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars Q1 FY 12 Q1 FY 13 Growth Q1 FY 12 Q1 FY 13 Growth Q1 FY 12 Q1 FY 13 Growth Q1 FY 12 Q1 FY 13 Growth Q1 FY 12 Q1 FY 13 Growth yoy (%) yoy (%) yoy (%) yoy
Slide 13: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Standalone Pharmacy
Operational Performance – Standalone Pharmacy ` Mio B t h Batch P ti l Particulars Q1 FY 12 Q1 FY 13 yoy % Upto FY No of Stores 311 291 2007 Revenue/store 2.20 2.55 15.7% Batch EBITDA /store 0.11 0.15 31.7% EBITDA Margin % 5 1% 5.1% 5 8% 5.8% 71 bps No of Stores 196 177 FY 2008 Revenue/store 1.69 2.
Slide 15: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total Estim ated AHEL's AHEL s Strategy for Expansion Project Share of Type of Cost Cost Focus on owned hospitals Location CoD* Hospital No of Beds (Rs.m io) (Rs.m io) – Plan to add 15 hospitals from the current 36 Mumbai Cluster – Plan to add 3,14
Slide 17: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance - Hospitals p • Operational Performance - Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Update on non hospital JVs, Associates
Update on non hospital JVs, Associates ` Mio Y-O-Y revenue growth of 10.2%. Particulars Q1 FY 12 Q1 FY 13 yoy (%) Expansion in EBITDA margins by 560 bps at 21.3% in Q1FY13 as compared to 15.7% in Q1FY12. Total Income 1,220 1,344 10.2% EBITDA 192 287 49.4% margin (%) 15.7% 21.3% 560 bps P fit aft
Slide 19: Q&A
Q&A 19
Slide 20: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital p ASH ‐ Chennai Chennai Hospital Tondiarpet ‐ Chennai Chennai Hospital FirstMed ‐ Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Madurai Madurai Hospital Karur Karur Hospital Kar
Slide 21: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description p Formula / Calculation Key y Driver Number of operating - Project execution Operating Beds beds Capital Expenditure x In-patient Bed Days In-patient Bed Days Brand Occupancy Billed Doctor reputation Quality of outcomes
Apollo Hospitals Enterprise — Q1 FY2013 Earnings Presentation on 6ix